These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 26730873)
1. Reply: Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics. Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE Ann Am Thorac Soc; 2016 Jan; 13(1):142-3. PubMed ID: 26730873 [No Abstract] [Full Text] [Related]
2. Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics. Collins JM; Kempker RR; Ziegler TR; Blumberg HM; Jones DP Ann Am Thorac Soc; 2016 Jan; 13(1):141-2. PubMed ID: 26730872 [No Abstract] [Full Text] [Related]
3. Metabolomics: Applications and Promise in Mycobacterial Disease. Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272 [TBL] [Abstract][Full Text] [Related]
4. Clinical metabolomics: a pivotal tool for companion diagnostic development and precision medicine. Tolstikov V; Akmaev VR; Sarangarajan R; Narain NR; Kiebish MA Expert Rev Mol Diagn; 2017 May; 17(5):411-413. PubMed ID: 28317395 [No Abstract] [Full Text] [Related]
5. Challenges in metabolomics-based disease molecular classification: an analytical perspective. Gao Y; Liu Q; Xu F Bioanalysis; 2017 May; 9(10):771-773. PubMed ID: 28520467 [No Abstract] [Full Text] [Related]
6. Metabolomics through the lens of precision cardiovascular medicine. Lam SM; Wang Y; Li B; Du J; Shui G J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553 [TBL] [Abstract][Full Text] [Related]
7. Integrative methods for analyzing big data in precision medicine. Gligorijević V; Malod-Dognin N; Pržulj N Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817 [TBL] [Abstract][Full Text] [Related]
8. [The diagnosis and treatment of rapidly growing non-tuberculous mycobacterial keratitis]. Guan HJ; Cheng ZP; Yin L; Wu YY; Hu N; Zhang JF; Shi HH Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):503-8. PubMed ID: 19957672 [TBL] [Abstract][Full Text] [Related]
10. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine. Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671 [TBL] [Abstract][Full Text] [Related]
11. [Nontuberculous mycobacterial diseases--difficult to diagnose and difficult to treat]. Uibu T; Kellomäki L; Järvenpää R; Risto V; Lumio J Duodecim; 2005; 121(11):1176-83. PubMed ID: 15999972 [No Abstract] [Full Text] [Related]
12. Non-tuberculous mycobacterial lymphadenitis in children: diagnosis and management. Amir J Isr Med Assoc J; 2010 Jan; 12(1):49-52. PubMed ID: 20450132 [TBL] [Abstract][Full Text] [Related]
13. Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine. Trifonova O; Knight RA; Lisitsa A; Melino G; Antonov AV Drug Discov Today; 2016 Jan; 21(1):103-110. PubMed ID: 26220091 [TBL] [Abstract][Full Text] [Related]
14. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. Esenboga S; Ayvaz DC; Cetinkaya PG; van der Burg M; Tezcan İ J Clin Immunol; 2016 Feb; 36(2):103-6. PubMed ID: 26707786 [No Abstract] [Full Text] [Related]
15. Feline mycobacterial infections. Gunn-Moore DA Vet J; 2014 Aug; 201(2):230-8. PubMed ID: 24685470 [TBL] [Abstract][Full Text] [Related]
19. A metabolomics approach to characterise and identify various Mycobacterium species. Olivier I; Loots du T J Microbiol Methods; 2012 Mar; 88(3):419-26. PubMed ID: 22301369 [TBL] [Abstract][Full Text] [Related]
20. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment. Dona AC; Coffey S; Figtree G Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]